Croda International Plc (LON:CRDA)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 5.09B +26.2% |
| Revenue (ttm) | 1.72B +3.4% |
| Net Income | 79.50M -43.2% |
| EPS | 0.57 -43.1% |
| Shares Out | 139.92M |
| PE Ratio | 63.88 |
| Forward PE | 21.66 |
| Dividend | 1.11 (3.05%) |
| Ex-Dividend Date | Aug 27, 2026 |
| Volume | 392,183 |
| Open | 3,639.00 |
| Previous Close | 3,668.00 |
| Day's Range | 3,604.00 - 3,663.00 |
| 52-Week Range | 2,488.00 - 3,699.00 |
| Beta | 0.96 |
| Analysts | Buy |
| Price Target | 3,707.86 (+1.98%) |
| Earnings Date | Feb 23, 2027 |
About Croda International
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfa... [Read more]
Financial Performance
In 2025, Croda International's revenue was 1.70 billion, an increase of 4.38% compared to the previous year's 1.63 billion. Earnings were 62.00 million, a decrease of -60.88%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for CRDA stock is "Buy." The 12-month stock price target is 3,708p, which is an increase of 1.98% from the latest price.
News
Croda International H1 Earnings Call Highlights
Croda International LON: CRDA said its first-half results met expectations as growth accelerated in the second quarter, supported by Consumer Care and a strong performance in Beauty Actives. The compa...
Croda International Earnings Call Transcript: H1 2026
First half results were in line with expectations, with profits outpacing sales and strong growth in Consumer Care, especially Beauty Actives. Transformation initiatives and innovation are driving margin expansion, and full-year guidance is reaffirmed.
Croda International Quarterly report: H1 2026
Croda International has published its H1 2026 quarterly earnings report on July 28, 2026.
Croda International Slides: H1 2026
Croda International has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 28, 2026.
Croda International Earnings Call Transcript: Q1 2026
Q1 2026 sales rose 1% at constant currency, with Consumer Care up and Life Sciences down. No material impact from Middle East conflict; full-year outlook unchanged, supported by strong order book, ongoing transformation, and price increases to offset inflation.
Croda International Earnings release: Q1 2026
Croda International released its Q1 2026 earnings on April 22, 2026, summarizing the period's financial results.
Croda International Earnings Call Transcript: H2 2025
Sales rose 7% in constant currency with strong growth in patented ingredients and Consumer Care. Transformation initiatives are driving margin recovery, with a target of over 20% operating margin by 2028 and free cash flow conversion above 12%.
Croda International Annual report: H2 2025
Croda International has published its H2 2025 annual report on February 24, 2026.
Croda International Annual report: H2 2025
Croda International has published its H2 2025 annual report on February 24, 2026.
Croda International Slides: H2 2025
Croda International has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 24, 2026.
Croda International shares jump after Standard Industries unit discloses stake
Shares of Croda International Plc surged 4.7% on Thursday, marking the British chemicals supplier's strongest daily gain since April 23. The rally came after a filing revealed that Standard Latitude M...
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
SEATTLE--(BUSINESS WIRE)--Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and ...